Overall, these results confirm that Rho pathways, specifically Rac1, activity is essential for maintaining the migratory morphology induced by HFD-derived exosomes and that its inhibition effectively reverts this phenotype, potentially contributing to the aggressive phenotype observed in cancer cells. Here, RAC1 is linked to cancer.